Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

LGT Alpha Generix Convergence Class A USD Fonds 32029167 / IE00BYZHSH67

1’510.51 USD
-3.64 USD
-0.24 %
25.11.2024
NAV

Nettoinventarwert (NAV)

1’510.51 USD -3.64 USD -0.24 %
Vortag 1’514.14 USD Datum 25.11.2024

LGT Alpha Generix Convergence Class A USD Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 302.92%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 164.45%
21Shares Ripple XRP ETP CH0454664043 137.47%
21Shares Fantom ETP CH1168929078 102.09%
21Shares Algorand ETP CH1146882316 93.41%
21Shares Injective Staking ETP CH1360612134 18.63%
21Shares Immutable ETP CH1360612142 8.49%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 163.46%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Cardano ETP CH1102728750 116.30%
21Shares Aave ETP CH1135202120 86.40%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 49.45%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 329.69%
21Shares Fantom ETP CH1168929078 211.89%
21Shares Staking Basket Index ETP CH1210548892 170.71%
21Shares Binance BNB ETP CH0496454155 168.82%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 162.98%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’696.85%
21Shares Bitcoin Core ETP CH1199067674 479.51%
21Shares Bitcoin ETP CH0454664001 464.90%
21Shares Fantom ETP CH1168929078 410.41%
21Shares Bitcoin Suisse ETP CH0496484640 369.11%

Fundamentaldaten

Valor 32029167
ISIN IE00BYZHSH67
Emittent LGT Capital Partners
Aufgelegt in Ireland
Auflagedatum 31.03.2016
Kategorie Alternative Inv Sonstige
Währung USD
Volumen 588’624’501.94
Depotbank BNP Paribas Securities Services, Dublin
Geschäftsjahresende 31.12.
Berichtsstand 05.06.2024

Anlagepolitik

So investiert der LGT Alpha Generix Convergence Class A USD Fonds: "LGT Alpha Generix Convergence SF is a sub-fund of Crown A GENERIX plc, Ireland. The objective is to generate long-term capital appreciation with principles designed to minimize the risk of capital loss, pursued through a continuously researched, active, rules based convergence trading strategy. "

ETP Performance: LGT Alpha Generix Convergence Class A USD Fonds

Performance 1 Jahr
1.50
Performance 2 Jahre
14.25
Performance 3 Jahre
26.27
Performance 5 Jahre
21.53
Performance 10 Jahre -